Latest Bedaquiline News & Updates

New Delhi, Jan 12 (IANS) Delhi’s Intermediate Reference Laboratory (IRL), Tuberculosis Centre, has achieved a major milestone with its first certification from the Central Tuberculosis Division (CTD), Government of India, to conduct Drug Susceptibility Testing (DST) for two drugs, an official said on Monday. Bedaquiline (BDQ) and Pretomanid (Pa), which will be tested, are two key drugs used globally for the treatment of drug-resistant tuberculosis (DR-TB), the official said.This certification …